Open AccessHIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage II colorectal cancer
Author(s) -
Alessandra Verdina,
Micol Di Segni,
Carla Azzurra Amoreo,
Isabella Sperduti,
Simonetta Buglioni,
Marcella Mottolese,
Giuliana Di Rocco,
Silvia Soddu
Publication year - 2020
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2020.7912
Subject(s) - colorectal cancer , oxaliplatin , cancer research , cancer , biology , medicine , oncology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom